The IEEE International Conference on Bioinformatics & Bioengineering (BIBE2024) November 27-29, 2024. Kragujevac, Serbia
Welcome to BIBE 2024
The series of BIBE Conferences, founded in 2000, is the longest-running IEEE Conference of its kind by inspiring many similar venues. The 24th annual IEEE International Conference on Bioinformatics and Bioengineering aims at building synergies among the complementary disciplines of Bioinformatics, Bioengineering and Biomedicine. These synergies have delivered advances for understanding a wide range of complex issues and problems in the fields of medicine, bioengineering and biological systems, health environmental science, public healthcare, forensics, wearable and assistive devices and more. These fields have improved the human condition by helping us understand living organisms at multiple levels, developing innovative implants and bio-prosthetics, and by improving tools and techniques for the detection, prevention and treatment of diseases. The BIBE series provides a common platform for cross-fertilization of ideas and for shaping knowledge and scientific achievements by bringing these disciplines into an interactive and engaging forum. Keeping this objective in mind, BIBE solicits original contributions in the following non-exclusive lists of areas.
Important Dates
• Submission of scientific contributions (full paper up to 8 pages) deadline: August 1, 2024, EXTENDED September 6, 2024
• Notification of acceptance deadline: August 30, 2024 EXTENDED September 20, 2024
• Early bird registration fee payment deadline: September 15, 2024 EXTENDED October 20, 2024
• Late registration fee payment deadline: November 15, 2024
Paper Submission
The submitted work should be original and not be published or concurrently submitted for publication elsewhere. Papers should be submitted electronically (through the BIBE website) in PDF format and should conform to IEEE specifications (single-space, double-column, 10-point font size, up to 8 pages). BIBE receives only full papers (up to 8 pages long). The Review Committee makes the decision of categorization of these papers based on their merit. More specifically, the categories are:
-
-
-
Full papers based on their quality after review (8 pages long with regular registration plus one extra page, if needed, with extra cost $100 according to IEEE CS policy).
-
Short papers based on their merit after review (5 pages long with regular registration plus one extra page, if needed, with extra cost $100 according to IEEE CS policy).
-
-
Full papers and short papers will be published in the same proceedings and will be presented in the sessions in a mixed order.
Paper Presentation & Publication
Each accepted paper should be presented by one of the authors and accompanied by at least one full registration fee payment, to guarantee publication in the proceedings. All accepted papers will be included in the proceedings of BIBE 2024 that will be published by the IEEE Computer Society at IEEE Xplore.
Special Issues:
Extended versions of the best papers of the conference will be invited for publication in a special issue of the THC journal (SCI Indexed).
Venue
The conference will be held in Hotel Kragujevac, Kragujevac, Serbia.
Keynote Speakers
- Prof. Wei Zhang – Dalian University of Technology, Dalian, China; Title: Application of Hydrogel in Cancer Therapy.
- Prof. Đorđe Jakovljević – Research Centre for Health and Life Sciences of Coventry University, United Kingdom; Title: Technological Innovations in Diagnosis of Heart Failure.
- Prof. Milica Radišić – University of Toronto, Canada; Title: 3D Printing of Bioelastomers and Granular Materials for Engineering of Organotypic Structures.
- Prof. Dimitris Fotiadis – University of Ioannina, Greece, Title: Leveraging Trust in Healthcare Through a Robust AI Trustworthiness Assessment Framework
- Prof. Milos Kojic – Houston Methodist Research Institute, USA, Title: Physics-Based Computational Models Within the Artificial Intelligence Scheme: Important Features
- Prof. Valentin Djonov – Institute of Anatomy, University of Bern, Title: How microbeam technology could change the radiooncology treatment
- Prof. Branislav Jeremić – University Hospital in Kragujevac, Title: What HPV + status brings to the treatment of HNC?
State Key Laboratory of Structural Analysis, Optimization and CAE Software for Industrial Equipment, School of Mechanics and Aerospace Engineering, Dalian University of Technology, Dalian, China
Title: Application of Hydrogel in Cancer Therapy
Professor of Cardiovascular and Lifestyle Medicine and Research Lead for Clinical Sciences and Translational Medicine at the Research Centre for Health and Life Sciences of Coventry University, United Kingdom
Title: Technological Innovations in Diagnosis of Heart Failure
Professor at the University of Toronto, Tier 1 Canada Research Chair in Organ-on-a-Chip Engineering and a Senior Scientist at the Toronto General Research Institute
Title: 3D Printing of Bioelastomers and Granular Materials for Engineering of Organotypic Structures
Prof. of Biomedical Engineering, University of Ioannina / IMBB-FORTH
Head of the Unit of Medical Technology and Intelligent Information Systems Editor in Chief IEEE Journal of Biomedical and Health Informatics, Ioannina, Greece
Title: Leveraging Trust in Healthcare Through a Robust AI Trustworthiness Assessment Framework
Houston Methodist Research Institute, USA
Bioengineering Research and Development Center, Serbia
Serbian Academy of Sciences and Arts, Serbia
Title: Physics-Based Computational Models Within the Artificial Intelligence Scheme: Important Features
After several years in neuro- and general surgery, in 1992 V. Djonov entered a research position in the Department of Clinical Research at the University of Bern, Switzerland.
Title: How microbeam technology could change the radiooncology treatment
School of Mathematics and Physics, Queen’s University Belfast, United Kingdom
Faculty of Business and IT, Ontario Tech University, Oshawa, Canada
Title: Assessing the Impact of Public Health Interventions and Simulating COVID-19 Spread in Northern Ireland Using the CP-ABM Approach
University Hospital in Kragujevac
Visiting professor Harvard University, Mayo Clinic, Thomas Jefferson University
Member of Academy of Sciences of South Africa.
Title: What HPV + status brings to the treatment of HNC?
Special Issues
Extended versions of the best papers of the conference will be invited for publication in a special issue of the THC journal (SCI Indexed).
Topics
BIOINFORMATICS
BIOENGINEERING